<DOC>
	<DOCNO>NCT02576847</DOCNO>
	<brief_summary>This study evaluate long-term safety once-daily application Omiganan topical gel subject severe papulopustular rosacea .</brief_summary>
	<brief_title>Study Evaluate Long-term Safety Once-Daily Omiganan Topical Gel</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>1 . Healthy , male nonpregnant female subject , 18 year age old . 2 . A diagnosis severe papulopustular rosacea use Investigator Global Assessment grade scale baseline 3 . Subjects presence telangiectasia Baseline 4 . Subjects presence facial erythema associate rosacea Baseline 1 . Subjects steroid rosacea subtype 3 ( phymatous rosacea ) . 2 . Subjects nodular rosacea 3 . Standard exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>